This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2017 Jun;13(6):317.

doi: 10.1038/nrneurol.2017.71. Epub 2017 May 5.

Neurodegenerative disease: Halting neurodegeneration - are repurposed drugs the answer?

PMID: 28474684
DOI: 10.1038/nrneurol.2017.71

Comment

Neurodegenerative disease: Halting neurodegeneration - are repurposed drugs the answer?

Heather Wood. Nat Rev Neurol. 2017 Jun.

. 2017 Jun;13(6):317.

doi: 10.1038/nrneurol.2017.71. Epub 2017 May 5.

Author

PMID: 28474684
DOI: 10.1038/nrneurol.2017.71

No abstract available

PubMed Disclaimer

Comment on

Repurposed drugs targeting eIF2α-P-mediated translational repression prevent neurodegeneration in mice.
Halliday M, Radford H, Zents KAM, Molloy C, Moreno JA, Verity NC, Smith E, Ortori CA, Barrett DA, Bushell M, Mallucci GR. Halliday M, et al. Brain. 2017 Jun 1;140(6):1768-1783. doi: 10.1093/brain/awx074. Brain. 2017. PMID: 28430857 Free PMC article.

Similar articles

Drug repurposing to target proteostasis and prevent neurodegeneration: accelerating translational efforts.
Mercado G, Hetz C. Mercado G, et al. Brain. 2017 Jun 1;140(6):1544-1547. doi: 10.1093/brain/awx107. Brain. 2017. PMID: 28549133 No abstract available.
Trazodone to change the risk of neurodegeneration: bedside to bench.
Camargos EF, Nóbrega OT. Camargos EF, et al. Brain. 2017 Aug 1;140(8):e47. doi: 10.1093/brain/awx149. Brain. 2017. PMID: 28641375 No abstract available.
Reply: Trazodone to change the risk of neurodegeneration: bedside to bench.
Halliday M, Mallucci GR. Halliday M, et al. Brain. 2017 Aug 1;140(8):e48. doi: 10.1093/brain/awx150. Brain. 2017. PMID: 28641370 No abstract available.
Targeting phosphorylation of eukaryotic initiation factor-2α to treat human disease.
Fullwood MJ, Zhou W, Shenolikar S. Fullwood MJ, et al. Prog Mol Biol Transl Sci. 2012;106:75-106. doi: 10.1016/B978-0-12-396456-4.00005-5. Prog Mol Biol Transl Sci. 2012. PMID: 22340715 Review.
The Integrated Stress Response and Phosphorylated Eukaryotic Initiation Factor 2α in Neurodegeneration.
Bond S, Lopez-Lloreda C, Gannon PJ, Akay-Espinoza C, Jordan-Sciutto KL. Bond S, et al. J Neuropathol Exp Neurol. 2020 Feb 1;79(2):123-143. doi: 10.1093/jnen/nlz129. J Neuropathol Exp Neurol. 2020. PMID: 31913484 Free PMC article. Review.

See all similar articles

Cited by

Antineuroinflammatory Activities and Neurotoxicological Assessment of Curcumin Loaded Solid Lipid Nanoparticles on LPS-Stimulated BV-2 Microglia Cell Models.
Ganesan P, Kim B, Ramalaingam P, Karthivashan G, Revuri V, Park S, Kim JS, Ko YT, Choi DK. Ganesan P, et al. Molecules. 2019 Mar 25;24(6):1170. doi: 10.3390/molecules24061170. Molecules. 2019. PMID: 30934561 Free PMC article.

References

1. Brain. 2017 Jun 1;140(6):1768-1783 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information